• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.05% Nasdaq Up 0.23%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    181.56 Up 1.20(0.67%) 3:02PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:180.36
    Open:181.42
    Bid:181.41 x 300
    Ask:181.61 x 100
    1y Target Est:210.59
    Beta:1.45
    Next Earnings Date:29-Jan-15ALXN Earnings announcement
    Day's Range:179.67 - 183.02
    52wk Range:129.80 - 203.30
    Volume:986,418
    Avg Vol (3m):1,107,400
    Market Cap:36.00B
    P/E (ttm):75.52
    EPS (ttm):2.40
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ALXNUp 0.67%36.00B
    AMGNDown 1.30%119.29B
    BAXUp 0.41%38.45B

    Key Statistics

    Forward P/E (1 yr):30.71
    P/S (ttm):17.23
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :5.20
    Quarterly EPS Est (Dec-14) :1.29
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):1.10

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback